Huijun Qiu

492 total citations
24 papers, 277 citations indexed

About

Huijun Qiu is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Allergy and Otorhinolaryngology. According to data from OpenAlex, Huijun Qiu has authored 24 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Immunology and Allergy and 7 papers in Otorhinolaryngology. Recurrent topics in Huijun Qiu's work include Allergic Rhinitis and Sensitization (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Asthma and respiratory diseases (5 papers). Huijun Qiu is often cited by papers focused on Allergic Rhinitis and Sensitization (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Asthma and respiratory diseases (5 papers). Huijun Qiu collaborates with scholars based in China, United States and Singapore. Huijun Qiu's co-authors include Qintai Yang, Xuekun Huang, Qingwu Wu, Lianxiong Yuan, Rui Zheng, Xinyue Wang, Yana Zhang, Zhou Ou, Zhou Fu and Pranela Rameshwar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Journal of Allergy and Clinical Immunology.

In The Last Decade

Huijun Qiu

23 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huijun Qiu China 11 115 89 74 65 63 24 277
Toshiyuki Nakasone Japan 10 49 0.4× 11 0.1× 45 0.6× 12 0.2× 47 0.7× 45 244
Milovan Dimitrijević Serbia 8 108 0.9× 5 0.1× 116 1.6× 77 1.2× 34 0.5× 37 281
Masanori Komatsu Japan 13 365 3.2× 108 1.2× 240 3.2× 103 1.6× 125 2.0× 43 490
Kenneth Hennrick United States 5 22 0.2× 6 0.1× 94 1.3× 62 1.0× 125 2.0× 10 356
Jugao Fang China 11 74 0.6× 6 0.1× 100 1.4× 27 0.4× 53 0.8× 41 312
Toshimichi Yasui Japan 11 236 2.1× 4 0.0× 153 2.1× 37 0.6× 71 1.1× 21 412
Tine Rosenberg Denmark 11 104 0.9× 2 0.0× 104 1.4× 29 0.4× 77 1.2× 20 278
Nikolaus Möckelmann Germany 13 178 1.5× 4 0.0× 196 2.6× 28 0.4× 86 1.4× 32 396
M. Müller Netherlands 6 8 0.1× 33 0.4× 53 0.7× 15 0.2× 84 1.3× 11 310

Countries citing papers authored by Huijun Qiu

Since Specialization
Citations

This map shows the geographic impact of Huijun Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huijun Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huijun Qiu more than expected).

Fields of papers citing papers by Huijun Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huijun Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huijun Qiu. The network helps show where Huijun Qiu may publish in the future.

Co-authorship network of co-authors of Huijun Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Huijun Qiu. A scholar is included among the top collaborators of Huijun Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huijun Qiu. Huijun Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Qiu, Huijun, Rong Zhang, Jiang Liu, et al.. (2025). Human Umbilical Cord–Mesenchymal Stem Cells Combined With Low Dosage Nintedanib Rather Than Using Alone Mitigates Pulmonary Fibrosis in Mice. Stem Cells International. 2025(1). 9445735–9445735. 1 indexed citations
4.
Qiu, Huijun, Jiang Liu, Zhou Ou, et al.. (2024). Inhibition of sphingosine 1-phosphate receptor 3 ameliorates bleomycin-induced pulmonary fibrosis by suppressing macrophage M2 polarization. Genes & Diseases. 12(3). 101244–101244. 1 indexed citations
5.
Qiu, Huijun, Chun‐Feng Liu, Qingwu Wu, et al.. (2024). An in vitro study of the impact of IL-17A and IL-22 on ciliogenesis in nasal polyps epithelium via the Hippo-YAP pathway. Journal of Allergy and Clinical Immunology. 154(5). 1180–1194. 7 indexed citations
7.
Wu, Qingwu, Yong Ren, Weihao Wang, et al.. (2022). Chinese Central Compartment Atopic Disease: The Clinical Characteristics and Cellular Endotypes Based on Whole-Slide Imaging. SHILAP Revista de lepidopterología. 11 indexed citations
8.
Qiu, Huijun, Zhou Ou, Jiang Liu, et al.. (2022). Hypoxic preconditioning improves the survival and pro-angiogenic capacity of transplanted human umbilical cord mesenchymal stem cells via HIF-1α signaling in a rat model of bronchopulmonary dysplasia. Biochemical and Biophysical Research Communications. 605. 111–118. 7 indexed citations
10.
Liu, Jiang, Zhou Ou, Huijun Qiu, et al.. (2021). Type 2 Alveolar Epithelial Cells Differentiated from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Mouse Pulmonary Fibrosis Through β-Catenin-Regulated Cell Apoptosis. Stem Cells and Development. 30(13). 660–670. 20 indexed citations
11.
Wu, Qingwu, Lianxiong Yuan, Huijun Qiu, et al.. (2021). Efficacy and safety of omalizumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 11(9). e047344–e047344. 24 indexed citations
12.
Wu, Qingwu, Yana Zhang, Xinyue Wang, et al.. (2021). Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis. International Archives of Allergy and Immunology. 183(3). 279–288. 56 indexed citations
13.
Wu, Qingwu, Jianning Chen, Yong Ren, et al.. (2021). Artificial intelligence for cellular phenotyping diagnosis of nasal polyps by whole-slide imaging. EBioMedicine. 66. 103336–103336. 29 indexed citations
14.
Li, Meijiao, Rui Zheng, Huijun Qiu, et al.. (2021). YAP Promotes Cell Proliferation and Epithelium-Derived Cytokine Expression via NF-κB Pathway in Nasal Polyps. Journal of Asthma and Allergy. Volume 14. 839–850. 7 indexed citations
15.
Qiu, Huijun, Rui Zheng, Xinyue Wang, et al.. (2021). Using the Internet Big Data to Investigate the Epidemiological Characteristics of Allergic Rhinitis and Allergic Conjunctivitis. Risk Management and Healthcare Policy. Volume 14. 1833–1841. 3 indexed citations
16.
Wu, Qingwu, Yuan Tian, Zongping Zhang, et al.. (2020). The top 100 most impactful articles and recent trends in nasopharyngeal carcinoma from 1970 to 2018: a bibliometric analysis. Journal of International Medical Research. 48(1). 1219695701–1219695701. 6 indexed citations
17.
Tian, Tian, Zhan‐Hong Chen, Zongheng Zheng, et al.. (2020). Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasis. Theranostics. 10(13). 5998–6010. 22 indexed citations
18.
Wu, Qingwu, Rui Zheng, Weihao Wang, et al.. (2019). The top 100 most influential articles in allergic rhinitis from 1970 to 2018: A bibliometric analysis. Journal of International Medical Research. 47(12). 6315–6336. 6 indexed citations
20.
Rameshwar, Pranela, Huijun Qiu, & Stephen F. Vatner. (2010). Stem cells in cardiac repair in an inflammatory microenvironment.. PubMed. 58(1). 127–46. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026